Outcome After Treatment of Pulmonary Aspergilloma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-10-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective analysis of surgery and/or bronchial embolisation for pulmonary aspergilloma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A retrospective chart analysis, based on the search results from a thoracic surgery database and an interventional radiology database. Outcome analysis of all surgically treated patients for a confirmed invasive aspergilloma. Comparisson with (preoperative) embolisation of the bronchial circulation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Fungal Diseases

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Catheterization, Bronchial Pneumonectomy Lobectomy Thoracoplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Embolisation

(preoperative) embolisation of the bronchial circulation

No interventions assigned to this group

Surgery

Any surgically treated patient with a functional lung resection (at least wedge resection)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histological proven Aspergilloma of the lung

Exclusion Criteria

* Treatment limited to the use of systemic antifungal agents

Minimum Eligible Age

1 Year

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Johnny Moons

Datamanager Thoracic Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Herbert Decaluwé, MD

Role: PRINCIPAL_INVESTIGATOR

UZ Leuven - dept. Thoracic Surgery

Laurence Bertrand, MSc

Role: PRINCIPAL_INVESTIGATOR

Katholic University Leuven

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Leuven

Leuven, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ASPERLEU

Identifier Type: -

Identifier Source: org_study_id